| The concise guide to pharmacology 2021/22: Introduction and other protein targets SPH Alexander, E Kelly, A Mathie, JA Peters, EL Veale, JF Armstrong, ... British journal of pharmacology 178, S1-S26, 2021 | 240 | 2021 |
| Surface-initiated polymerization from barium titanate nanoparticles for hybrid dielectric capacitors SA Paniagua, Y Kim, K Henry, R Kumar, JW Perry, SR Marder ACS applied materials & interfaces 6 (5), 3477-3482, 2014 | 174 | 2014 |
| Roles for regulator of G protein signaling proteins in synaptic signaling and plasticity KJ Gerber, KE Squires, JR Hepler Molecular pharmacology 89 (2), 273-286, 2016 | 120 | 2016 |
| Genetic analysis of rare human variants of regulators of G protein signaling proteins and their role in human physiology and disease KE Squires, C Montañez-Miranda, RR Pandya, MP Torres, JR Hepler Pharmacological reviews 70 (3), 446-474, 2018 | 64 | 2018 |
| Norepinephrine regulates cocaine-primed reinstatement via α1-adrenergic receptors in the medial prefrontal cortex KT Schmidt, JP Schroeder, SL Foster, K Squires, BM Smith, EG Pitts, ... Neuropharmacology 119, 134-140, 2017 | 32 | 2017 |
| The concise guide to PHARMACOLOGY 2023/24: introduction and other protein targets SPH Alexander, E Kelly, AA Mathie, JA Peters, EL Veale, JF Armstrong, ... British journal of pharmacology 180, S1-S22, 2023 | 28 | 2023 |
| Regulator of G protein signaling 14 (RGS14) is expressed pre-and postsynaptically in neurons of hippocampus, basal ganglia, and amygdala of monkey and human brain KE Squires, KJ Gerber, JF Pare, MR Branch, Y Smith, JR Hepler Brain Structure and Function 223, 233-253, 2018 | 28 | 2018 |
| ATI-2173, a novel liver-targeted non-chain-terminating nucleotide for hepatitis B virus cure regimens KE Squires, DL Mayers, GR Bluemling, AA Kolykhalov, DB Guthrie, ... Antimicrobial Agents and Chemotherapy 64 (9), 10.1128/aac. 00836-20, 2020 | 27 | 2020 |
| 14-3-3γ binds regulator of G protein signaling 14 (RGS14) at distinct sites to inhibit the RGS14: Gαi–AlF4− signaling complex and RGS14 nuclear localization KJ Gerber, KE Squires, JR Hepler Journal of Biological Chemistry 293 (38), 14616-14631, 2018 | 17 | 2018 |
| RGS14 regulates PTH-and FGF23-sensitive NPT2A-mediated renal phosphate uptake via binding to the NHERF1 scaffolding protein PA Friedman, WB Sneddon, T Mamonova, C Montanez-Miranda, ... Journal of Biological Chemistry 298 (5), 2022 | 12 | 2022 |
| Human bacterial artificial chromosome (BAC) transgenesis fully rescues noradrenergic function in dopamine β-hydroxylase knockout mice JF Cubells, JP Schroeder, ES Barrie, DF Manvich, W Sadee, T Berg, ... PLoS One 11 (5), e0154864, 2016 | 10 | 2016 |
| Human genetic variants disrupt RGS14 nuclear shuttling and regulation of LTP in hippocampal neurons KE Squires, KJ Gerber, MC Tillman, DJ Lustberg, C Montañez-Miranda, ... Journal of Biological Chemistry 296, 2021 | 9 | 2021 |
| Phase 1 Results for ATI-2173, a novel active site polymerase inhibitor nucleotide (ASPIN), in HBV-infected subjects D Mayers, A Jucov, I Anastasiy, N Ghicavii, L Ogilvie, K Squires, ... J Hepatol 75 (2), S743, 2021 | 8 | 2021 |
| A randomized phase 1b trial of the active site polymerase inhibitor nucleotide ATI‐2173 in patients with chronic hepatitis B virus infection KE Squires, L Ogilvie, A Jucov, I Anastasiy, N Ghicavii, J Huguet, ... Journal of viral hepatitis 30 (1), 19-28, 2023 | 6 | 2023 |
| Genetic variants disrupt human RGS14 binding to NHERF1 and regulation of NPT2A-mediated phosphate transport PA Friedman, T Mamonova, CE Magyar, KE Squires, WB Sneddon, ... BioRxiv, 540781, 2019 | 6 | 2019 |
| Active site polymerase inhibitor nucleotides (ASPINs): Potential agents for chronic HBV cure regimens RG Gish, T Asselah, K Squires, D Mayers Antiviral Chemistry and Chemotherapy 30, 20402066221138705, 2022 | 4 | 2022 |
| Sustained 12 week off treatment antiviral efficacy of ATI-2173, a novel active site polymerase inhibitor nucleotide, combined with tenofovir disoproxil fumarate in chronic … M Tomas, A Jucov, I Anastasiy, L Ogilvie, K Fusaro, K Squires, D Mayers Journal of Hepatology 77, S73, 2022 | 4 | 2022 |
| ATI-2173, a novel active site polymerase inhibitor nucleotide (ASPIN), for HBV cure regimens Is well tolerated and has favorable pharmacokinetics in healthy volunteers D Mayers, K Squires, L Ogilvie, G Morelli, J Huguet, R Melara, ... HBV-TAG, 11-12, 2021 | 2 | 2021 |
| Regulators of G protein Signaling (RGS) proteins in GtoPdb v. 2021.2 KE Ahlers-Dannen, M Alqinyah, C Bodle, JB Dagher, B Chakravarti, ... IUPHAR/BPS Guide to Pharmacology CITE 2021 (2), 2021 | 1 | 2021 |
| ATI-2173, a novel phosphoramidate nucleoside prodrug for HBV cure regimens D Mayers, K Squires, R Rush, A De La Rosa Journal of Hepatology 73, S864, 2020 | 1 | 2020 |
